Status:

TERMINATED

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

Lead Sponsor:

University of California, San Diego

Collaborating Sponsors:

Genentech, Inc.

Conditions:

Age-Related Macular Degeneration

Eligibility:

All Genders

50+ years

Phase:

PHASE2

PHASE3

Brief Summary

To determine if patients treated early after diagnosis of wet age-related macular degeneration can return/maintain to their baseline pre-disease BCVA.

Detailed Description

We will conduct an open label, multi-center study of naïve AMD patients that are identified early upon disease progression (had a normal VA, FA or OCT within 4 months prior to entry) to assess if trea...

Eligibility Criteria

Inclusion

  • Ability to provide written informed consent and comply with study assessments for the full duration of the study
  • Age \> 50 years
  • Naïve wet-AMD within 4 months of disease onset (for GALLEY patients) and within 3 months of disease onset for all others
  • Patients that have lost \> 5 letters from baseline best vision
  • BCVA 20/25-20/320

Exclusion

  • Pregnancy (positive pregnancy test) or lactation
  • Premenopausal women not using adequate contraception. The following are considered effective means of contraception: surgical sterilization or use of oral contraceptives, barrier contraception with either a condom or diaphragm in conjunction with spermicidal gel, an IUD, or contraceptive hormone implant or patch.
  • Any other condition that the investigator believes would pose a significant hazard to the subject if the investigational therapy were initiated
  • Participation in another simultaneous medical investigation or trial which includes an intervention (Patients could be participating in a non-interventional study such as the GALLEY study)
  • Juxtafoveal and extrafoveal wet-AMD

Key Trial Info

Start Date :

July 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2015

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01402544

Start Date

July 1 2011

End Date

March 1 2015

Last Update

August 28 2019

Active Locations (4)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (4 locations)

1

California Retina Consultants

Bakersfield, California, United States, 93309

2

Shiley Eye Center, UCSD

La Jolla, California, United States, 92093

3

California Retina Consultants

Santa Barbara, California, United States, 93103

4

Medical Center Ophthalmology Associates

San Antonio, Texas, United States, 78240